Home  |  Site Map  | Contact
Text size: AA   AA   AA

Press Releases

2012 Press Releases

Listed below are all of the QLT press releases available for the year you have selected.

December 24

QLT Announces Exclusive Option Agreement for Potential Sale of Punctal Plug Delivery System

PDF Format

December 6

QLT Announces Reduction in Force

PDF Format

November 7

QLT Announces Third Quarter 2012 Results

PDF Format

October 24

QLT Shows Positive Efficacy Trends From Data in Plug Combinations in Phase II Studies for Glaucoma Using Latanoprost Punctal Plug Delivery System

PDF Format

September 27

QLT Announces Share Repurchase Program

PDF Format

September 24

QLT Announces Sale of Visudyne® to Valeant Pharmaceuticals

PDF Format

August 2

QLT Announces Second Quarter 2012 Results

PDF Format

July 9

QLT Board of Directors Issues Letter to Shareholders Outlining New Corporate Strategy

PDF Format

June 4

QLT Announces Results of 2012 Annual Meeting of Shareholders

PDF Format

May 31

QLT Affirms Commitment to Return Capital to Shareholders

PDF Format

May 24

QLT Highlights Strategic Initiatives to Enhance Shareholder Value

PDF Format

May 24

QLT Postpones Annual General Meeting of Shareholders

PDF Format

May 23

QLT Responds With an Open Letter to Stockholders

PDF Format

May 23

QLT Announces Notification of Legal Proxy Action in Advance of Annual Meeting of Stockholders

PDF Format

May 3

QLT Announces First Quarter 2012 Results

PDF Format

April 19

Media Advisory: QLT to Report First Quarter Financial Results on May 3, 2012

PDF Format

April 16

QLT Announces the Appointment of Christopher Muller as Chief Commericial Officer

PDF Format

April 2

Media Advisory: QLT Announces QLT091001 Presentation at ARVO

PDF Format

March 19

QLT Receives Orphan Drug Designation for Visudyne for Treatment of Central Serous Chorioretinopathy

PDF Format

March 8

Media Advisory: QLT to Present at ROTH Capital Partners Annual Growth Stock Conference

PDF Format

March 1

QLT Announces Positive Preliminary Results from Phase 1b Trial of QLT091001 in Subjects with Retinitis Pigmentosa Due to RPE65 and LRAT Mutations

PDF Format

February 23

Media Advisory: QLT to Present at the 2012 RBC Capital Markets' Global Healthcare Conference

PDF Format

February 23

QLT Announces Fourth Quarter and Year End 2011 Results

PDF Format

February 16

Media Advisory: QLT to Report 2011 Fourth Quarter and Year End Financial Results on February 23, 2012

PDF Format

February 8

Media Advisory: QLT to Present at the Leerink Swann 2012 Global Healthcare Conference

PDF Format

January 9

Media Advisory: QLT to Present at the J.P. Morgan Healthcare Conference

PDF Format

 
 
Copyright © 2000-2015 QLT Inc. Legal Terms for use of site and Privacy Policy | Disclaimer
Vancouver Web Design by Graphically Speaking